{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:23:31Z","timestamp":1788881011222,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["OCENW.KLEIN.268"],"award-info":[{"award-number":["OCENW.KLEIN.268"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.molmed.2021.09.004","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T05:36:43Z","timestamp":1633757803000},"page":"1095-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Sanne G.S.","family":"Verberk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten L.","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Lauterbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eicke","family":"Latz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7852-2891","authenticated-orcid":false,"given":"Jan","family":"Van den Bossche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2021.09.004_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.molmed.2021.09.004_bb0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/2047487319869400","article-title":"Lifestyle factors and high-risk atherosclerosis: pathways and mechanisms beyond traditional risk factors","volume":"27","author":"Lechner","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0015","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2021.09.004_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: from plaques to genes to statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.09.004_bb0025","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.09.004_bb0030","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/cvr\/cvz166","article-title":"Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology","volume":"115","author":"Ketelhuth","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.molmed.2021.09.004_bb0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tcm.2008.11.004","article-title":"Monocyte-endothelial cell interactions in the development of atherosclerosis","volume":"18","author":"Mestas","year":"2008","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.molmed.2021.09.004_bb0040","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/CIRCRESAHA.118.312804","article-title":"Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models","volume":"123","author":"Kim","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2021.09.004_bb0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.09.004_bb0050","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.celrep.2018.10.092","article-title":"A defective pentose phosphate pathway reduces inflammatory macrophage responses during hypercholesterolemia","volume":"25","author":"Baardman","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2021.09.004_bb0055","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.ATV.0000166517.18801.a7","article-title":"Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis","volume":"25","author":"Schrijvers","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0060","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0065","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1038\/ncomms13457","article-title":"Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis","volume":"7","author":"Pinkosky","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2021.09.004_bb0070","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.09.004_bb0075","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","article-title":"Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT","volume":"132","author":"Bohula","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2021.09.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2019.101006","article-title":"ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: an updated review","volume":"77","author":"Feng","year":"2020","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.molmed.2021.09.004_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011662","article-title":"Efficacy and safety of bempedoic acid in patients with hypercholesterolemia and statin intolerance","volume":"8","author":"Laufs","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.molmed.2021.09.004_bb0090","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11612","article-title":"Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation","volume":"5","author":"Covarrubias","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.molmed.2021.09.004_bb0095","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.immuni.2019.11.009","article-title":"Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase","volume":"51","author":"Lauterbach","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2021.09.004_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2021.09.004_bb0105","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.09.004_bb0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jacc.2018.04.054","article-title":"The evolving future of PCSK9 inhibitors","volume":"72","author":"Rosenson","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40259-019-00399-6","article-title":"Small interfering RNA therapeutic inclisiran: a new approach to targeting PCSK9","volume":"34","author":"German","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.molmed.2021.09.004_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/CRD.0000000000000218","article-title":"Bempedoic acid (ETC-1002)","volume":"27","author":"Zagelbaum","year":"2019","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.molmed.2021.09.004_bb0125","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.molmed.2017.09.001","article-title":"Targeting ATP-citrate lyase in hyperlipidemia and metabolic disorders","volume":"23","author":"Pinkosky","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2021.09.004_bb0130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/ATVBAHA.116.308963","article-title":"Prevention of diet-induced metabolic dysregulation, inflammation, and atherosclerosis in Ldlr(-\/-) mice by treatment with the ATP-citrate lyase inhibitor bempedoic acid","volume":"37","author":"Samsoondar","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/2047487319864671","article-title":"Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy","volume":"27","author":"Ballantyne","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2020.12.023","article-title":"Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: a randomized clinical trial","volume":"320","author":"Rubino","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.molmed.2021.09.004_bb0145","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-020-01308-w","article-title":"Bempedoic acid: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.molmed.2021.09.004_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2021.09.004_bb0155","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2021.09.004_bb0160","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.09.004_bb0165","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00018-013-1289-1","article-title":"Inflammation and immune system interactions in atherosclerosis","volume":"70","author":"Legein","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2021.09.004_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrcardio.2014.173","article-title":"Macrophage subsets in atherosclerosis","volume":"12","author":"Chinetti-Gbaguidi","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","article-title":"Distribution of macrophage polarization markers in human atherosclerosis","volume":"225","author":"St\u00f6ger","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.molmed.2021.09.004_bb0180","doi-asserted-by":"crossref","first-page":"35234","DOI":"10.1038\/srep35234","article-title":"Bone marrow-derived and peritoneal macrophages have different inflammatory response to oxLDL and M1\/M2 marker expression \u2013 implications for atherosclerosis research","volume":"6","author":"Bisgaard","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2021.09.004_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002860","article-title":"Systematic evaluation of the cellular innate immune response during the process of human atherosclerosis","volume":"5","author":"van Dijk","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.molmed.2021.09.004_bb0190","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/CIRCRESAHA.120.316770","article-title":"Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics","volume":"127","author":"Depuydt","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2021.09.004_bb0195","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.09.004_bb0200","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1194\/jlr.M030528","article-title":"AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism","volume":"54","author":"Pinkosky","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2021.09.004_bb0205","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1194\/jlr.M035212","article-title":"ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK","volume":"54","author":"Filippov","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2021.09.004_bb0210","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s42255-020-0245-2","article-title":"Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK beta1 isoforms","volume":"2","author":"Pinkosky","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.molmed.2021.09.004_bb0215","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1172\/JCI58577","article-title":"Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity","volume":"121","author":"Galic","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2021.09.004_bb0220","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00109-019-01863-0","article-title":"The vital role of ATP citrate lyase in chronic diseases","volume":"98","author":"Khwairakpam","year":"2019","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2021.09.004_bb0225","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1074\/jbc.RA118.006685","article-title":"ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis","volume":"294","author":"Bazilevsky","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.09.004_bb0230","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/bi992159y","volume":"39","author":"Potapova","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.molmed.2021.09.004_bb0235","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1074\/jbc.M113.524587","article-title":"Toll-like receptor agonists promote prolonged triglyceride storage in macrophages","volume":"289","author":"Huang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.09.004_bb0240","doi-asserted-by":"crossref","first-page":"39976","DOI":"10.1074\/jbc.M110.182915","article-title":"A mouse macrophage lipidome","volume":"285","author":"Dennis","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.09.004_bb0245","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1189\/jlb.1111537","article-title":"Mechanisms of triglyceride accumulation in activated macrophages","volume":"92","author":"Feingold","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0250","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1038\/s41467-020-17881-3","article-title":"Triacylglycerol synthesis enhances macrophage inflammatory function","volume":"11","author":"Castoldi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2021.09.004_bb0255","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ni.2833","article-title":"TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation","volume":"15","author":"Everts","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2013.09.037","article-title":"ATP-citrate lyase is essential for macrophage inflammatory response","volume":"440","author":"Infantino","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2021.09.004_bb0265","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.cell.2015.11.045","article-title":"Limiting cholesterol biosynthetic flux spontaneously engages type I IFN signaling","volume":"163","author":"York","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.09.004_bb0270","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1038\/s41467-019-11606-x","article-title":"Protein prenylation restrains innate immunity by inhibiting Rac1 effector interactions","volume":"10","author":"Akula","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2021.09.004_bb0275","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cell.2012.06.054","article-title":"Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses","volume":"151","author":"Spann","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.09.004_bb0280","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.molcel.2016.05.029","article-title":"Interplay between metabolism and epigenetics: a nuclear adaptation to environmental changes","volume":"62","author":"Etchegaray","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2021.09.004_bb0285","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.09.004_bb0290","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41590-019-0453-7","article-title":"Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses","volume":"20","author":"Langston","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0295","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1038\/s41467-020-20141-z","article-title":"Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques","volume":"11","author":"Baardman","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2021.09.004_bb0300","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Jha","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2021.09.004_bb0305","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4049\/jimmunol.0901698","article-title":"Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation","volume":"185","author":"Rodriguez-Prados","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0310","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1074\/jbc.M113.522037","article-title":"Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype","volume":"289","author":"Freemerman","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.09.004_bb0315","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1074\/jbc.M115.676817","article-title":"Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression","volume":"291","author":"Meiser","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.09.004_bb0320","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.3390\/cancers13123054","article-title":"Myeloid-Specific Acly deletion alters macrophage phenotype in vitro and in vivo without affecting tumor growth","volume":"13","author":"de Goede","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.molmed.2021.09.004_bb0325","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.3389\/fimmu.2018.02858","article-title":"Polarization of human macrophages by interleukin-4 does not require ATP-citrate lyase","volume":"9","author":"Namgaladze","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0330","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41590-019-0539-2","article-title":"Endogenous oxidized phospholipids reprogram cellular metabolism and boost hyperinflammation","volume":"21","author":"Di Gioia","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0335","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cell.2009.05.047","article-title":"Control of inducible gene expression by signal-dependent transcriptional elongation","volume":"138","author":"Hargreaves","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.09.004_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002401","article-title":"Mechanisms establishing TLR4-responsive activation states of inflammatory response genes","volume":"7","author":"Escoubet-Lozach","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molmed.2021.09.004_bb0345","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2010.02.008","article-title":"Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages","volume":"32","author":"Ghisletti","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2021.09.004_bb0350","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/cb500846u","article-title":"Metabolic regulation of histone post-translational modifications","volume":"10","author":"Fan","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0355","doi-asserted-by":"crossref","first-page":"669920","DOI":"10.3389\/fimmu.2021.669920","article-title":"Myeloid ATP citrate lyase regulates macrophage inflammatory responses in vitro without altering inflammatory disease outcomes","volume":"12","author":"Verberk","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0360","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.15252\/emmm.201404170","article-title":"Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions","volume":"6","author":"Hoeksema","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2021.09.004_bb0365","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/jpet.111.183640","article-title":"Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifs","volume":"339","author":"Needham","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.molmed.2021.09.004_bb0370","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3389\/fphar.2019.01242","article-title":"Targeting histone deacetylases in myeloid cells inhibits their maturation and inflammatory function with limited effects on atherosclerosis","volume":"10","author":"Luque-Martin","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molmed.2021.09.004_bb0375","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","article-title":"Fatty acid transport protein 2 reprograms neutrophils in cancer","volume":"569","author":"Veglia","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.09.004_bb0380","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1806747","article-title":"Mendelian randomization study of ACLY and cardiovascular disease","volume":"380","author":"Ference","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.09.004_bb0385","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.celrep.2016.09.069","article-title":"ATP-citrate lyase controls a glucose-to-acetate metabolic switch","volume":"17","author":"Zhao","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2021.09.004_bb0390","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","article-title":"Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate","volume":"579","author":"Zhao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.09.004_bb0395","doi-asserted-by":"crossref","first-page":"E1528","DOI":"10.1073\/pnas.1614268114","article-title":"ACSS2-mediated acetyl-CoA synthesis from acetate is necessary for human cytomegalovirus infection","volume":"114","author":"Vysochan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.09.004_bb0400","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cell.2018.08.040","article-title":"Acetate production from glucose and coupling to mitochondrial metabolism in mammals","volume":"175","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.09.004_bb0405","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cellimm.2018.01.009","article-title":"Metabolic regulation of macrophages in tissues","volume":"330","author":"Van den Bossche","year":"2018","journal-title":"Cell. Immunol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491421002525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491421002525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:24:42Z","timestamp":1761463482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491421002525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1471491421002525"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2021.09.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2021.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}